Development and Validation of an Algorithm to Predict Stillbirth Gestational Age in Medicaid Billing Records.

Medicaid gestational age pregnancy administrative claims stillbirth

Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
20 Sep 2024
Historique:
received: 30 01 2024
revised: 14 08 2024
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 22 9 2024
Statut: aheadofprint

Résumé

With Medicaid covering half of US pregnancies, Medicaid Analytic eXtract (MAX) provides a valuable data source to enrich understanding about stillbirth etiologies. We developed and validated a claims-based algorithm to predict GA at stillbirth. We linked the stillbirths identified in MAX 1999-2013 to Florida Fetal Death Records (FDRs) to obtain clinical estimates of GA (N=825). We tested several algorithms including using a fixed median GA, median GA at the time of specific prenatal screening tests, and expanded versions considering additional predictors of stillbirth within including linear regression and random forest models. We estimated the proportion of pregnancies with differences of ± 1, 2, 3 and 4 weeks between the predicted and FDR GA and the model mean square error (MSE). We validated the selected algorithms in two external samples. The best performing algorithm was a random forest model (MSE of 12.67 weeks2) with 84% of GAs within ± 4 weeks. Assigning a fixed GA of 28 weeks resulted in an MSE of 60.21 weeks2 and proportions of GA within ± 4 weeks of 32%. We observed consistent results in the external samples. Our prediction algorithm for stillbirths can facilitate pregnancy research in the Medicaid population.

Identifiants

pubmed: 39307537
pii: 7762597
doi: 10.1093/aje/kwae369
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Thuy N Thai (TN)

Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA.
Department of Pharmaceutical Outcomes and Policy, College of Pharmacy University of Florida, Gainesville, Florida.
Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, Florida.

Nicole E Smolinski (NE)

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy University of Florida, Gainesville, Florida.
Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, Florida.

Sabina Nduaguba (S)

Department of Pharmaceutical Systems and Policy, College of Pharmacy West Virginia University, Morgantown, West Virginia.
West Virginia University Cancer Institute, Morgantown, West Virginia.

Steven Bird (S)

Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.

Loreen Straub (L)

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Brian T Bateman (BT)

Department of Anesthesiology, Perioperative, and Pain Medicine, School of Medicine Stanford University, Stanford California.
Department of Epidemiology and Population Health, School of Medicine Stanford University, Stanford California.

Sonia Hernandez-Diaz (S)

Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Krista F Huybrechts (KF)

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Sonja A Rasmussen (SA)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Almut G Winterstein (AG)

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy University of Florida, Gainesville, Florida.
Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, Florida.
Department of Epidemiology, College of Public Health & Health Professionals and College of Medicine University of Florida, Gainesville, Florida.

Classifications MeSH